Stay updated on Oral Oteseconazole for Recurrent Vaginal Candidiasis Clinical Trial
Sign up to get notified when there's something new on the Oral Oteseconazole for Recurrent Vaginal Candidiasis Clinical Trial page.

Latest updates to the Oral Oteseconazole for Recurrent Vaginal Candidiasis Clinical Trial page
- Check6 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check13 days agoChange DetectedThe ClinicalTrials.gov footer revision label changed from v3.7.0 to v3.7.1. The page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe study page now shows a new Revision: v3.7.0 tag, signaling an update to the record. Several older documents and items (e.g., Statistical Analysis Plan, Study Protocol, PDFs, and related metadata) were removed from the history on the page.SummaryDifference17%

- Check55 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6, indicating a minor page version update.SummaryDifference0.1%

- Check76 days agoChange DetectedThe page now displays Revision: v3.6.5, replacing the previous v3.6.4. This indicates a minor site update with no evident changes to the study content or its presentation.SummaryDifference0.1%

- Check91 days agoChange DetectedThe page's revision label updated from v3.6.3 to v3.6.4, reflecting a small maintenance update to the page's revision history.SummaryDifference0.1%

Stay in the know with updates to Oral Oteseconazole for Recurrent Vaginal Candidiasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Oteseconazole for Recurrent Vaginal Candidiasis Clinical Trial page.